Idorsia Pharmaceuticals Ltd Revenue and Competitors
Estimated Revenue & Valuation
- Idorsia Pharmaceuticals Ltd's estimated annual revenue is currently $327.2M per year.
- Idorsia Pharmaceuticals Ltd's estimated revenue per employee is $182,000
Employee Data
- Idorsia Pharmaceuticals Ltd has 1798 Employees.
Idorsia Pharmaceuticals Ltd's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Patent Counsel | Reveal Email/Phone |
2 | Sn VP, Head Clinical Science | Reveal Email/Phone |
3 | VP, Head preclinical project management | Reveal Email/Phone |
4 | Head Pathology | Reveal Email/Phone |
5 | Head Drug Discovery Chemistry, Member the Idorsia Leadership Team | Reveal Email/Phone |
6 | Head Pharmaceutical Development and Commercial Supplies , Sr. VP | Reveal Email/Phone |
7 | SVP, Head Chemical Development and Commercial Manufacturing | Reveal Email/Phone |
8 | Head IT US | Reveal Email/Phone |
9 | VP, Head Market Access US | Reveal Email/Phone |
10 | VP, Head Global Quality | Reveal Email/Phone |
Idorsia Pharmaceuticals Ltd Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 26 | -4% | $15.7M | N/A |
#2 | $1.4M | 21 | -50% | $21.2M | N/A |
#3 | $41.9M | 293 | 8% | $6M | N/A |
#4 | $6M | 53 | -22% | $216.8M | N/A |
#5 | $0M | 2 | 0% | $33.3M | N/A |
#6 | $26M | 182 | 0% | N/A | N/A |
#7 | $30.9M | 221 | -26% | $64.6M | N/A |
#8 | $28.6M | 205 | -22% | $46.8M | N/A |
#9 | $249.1M | 1340 | 15% | $75M | N/A |
#10 | $12.4M | 95 | 3% | N/A | N/A |
What Is Idorsia Pharmaceuticals Ltd?
N/A
Total Funding
1798
Number of Employees
$327.2M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Idorsia Pharmaceuticals Ltd News
2022-04-19 - Myocardial Infarction (MI) Therapeutics Market to 2030 Insights ...
... Pfizer Inc, CeleCor Therapeutics, Idorsia Pharmaceuticals Ltd. ... there are various specific antidotes of these pharmaceutical drugs...
2022-04-19 - Investegate |Idorsia Pharmaceuticals Ltd Announcements | Idorsia ...
Idorsia Ltd (SIX: IDIA) today announced its financial results for the ... two products in two of the world's largest pharmaceutical markets.
2022-04-13 - PIVLAZ (clazosentan) Idorsia's first commercial product now ...
Idorsia Ltd (SIX: IDIA) and Idorsia Pharmaceuticals Japan today announced that PIVLAZ (clazosentan) is now available to physicians in Japan...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $365.8M | 1802 | N/A | N/A |
#2 | $681.5M | 1803 | 5% | N/A |
#3 | $75M | 1806 | 5% | N/A |
#4 | $457.1M | 1814 | N/A | N/A |
#5 | $300M | 1815 | N/A | N/A |